AB0 System Determination and Control Rules
Blood group assignment within the AB0 system is determined via the agglutination reaction. To eliminate laboratory errors and false results, the procedure requires mandatory and strict controls:
- Serum control. AB (IV) serum is used. It is known to contain no group-specific antibodies, which verifies the absence of spontaneous non-specific clumping.
- Antigen control. Erythrocytes with a known set of antigens—specifically standard A (II) and B (III) group cells—are introduced into the reaction.
- Negative control. Type 0 (I) erythrocytes are used because their membranes completely lack agglutinogens of this system.
Direct Method for Rh Factor Detection
To detect the Rh antigen located directly on the erythrocyte membrane, a direct agglutination method is employed.
Anti-Rh sera serve as the diagnostic reagents. The primary requirement for this test is the use of at least two different lots of such sera, ensuring result reliability. The reaction mechanism is straightforward: antibodies from the added serum locate the Rh antigen on the test erythrocytes, interact with it, and cause the cells to clump (agglutinate). Standard Rh-positive and Rh-negative erythrocytes representing all known blood groups are mandatory for test validation.
Indirect Coombs Test: Searching for Hidden Threats
In certain clinical scenarios, antibodies are present in the blood that bind to Rh-positive erythrocytes without producing a visible clumping pattern. These are termed incomplete (univalent) antibodies. Due to their structure, they cannot independently link erythrocytes into a lattice (agglutinate).
To detect such "hidden" antibodies, the indirect Coombs test is used. The procedure is as follows:
- Antiglobulin serum is added to the system already containing anti-Rh antibodies and Rh-positive erythrocytes.
- This serum contains antibodies directed against human immunoglobulins.
- The added antiglobulin antibodies locate the incomplete antibodies already firmly fixed to the erythrocyte surface.
- Binding occurs, forming structural "bridges" between cells, which makes agglutination visually detectable.
Clinical Significance of the Coombs Test
This method is critical in hematology and obstetric practice. It is ordered to diagnose conditions associated with intravascular hemolysis and to detect hemolytic disease of the newborn (HDN) secondary to Rh incompatibility.
A classic example of this pathology is the development of HDN. If an Rh-negative mother forms antibodies against the Rh factor of her fetus, these antibodies freely cross the placenta. Upon entering the fetal circulation, they bind to the fetal erythrocytes. The indirect Coombs test allows laboratory detection of such erythrocyte-bound antibodies. Furthermore, the principle of this method has found additional application in microbiology to detect incomplete antibodies directed against various microbes.